Product Name: ROCK1 (910-916) pY913
Product Number: PE-04APL99
Size: 200 µg      Price:47.00
1 mg      $US94.00
5 mg      206.00
Peptide Name: ROCK1 (910-916) pY913

Product Use: Services as a blocking peptide for use with the ROCK1-pY913 rabbit polyclonal antibody (Cat. No.: AB-PK798) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located just before Rho-Binding domain. This is the major in vivo phosphorylation site in ROCK1. The effect of its phosphorylation is unclear.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Homo sapiens

Peptide Sequence: EEQ-pY-FEL

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: βAla-Cys
Peptide Modifications Other: Phosphorylated

Peptide Molecular Mass Calculated: 1210.19 Da

Peptide Purity Percent after Synthesis and Purification: >95

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Related Product 1: ROCK1 - pY913 phosphosite-specific antibody (Cat. No.: AB-PK798)

Scientific Background: ROCK1 (ROK-beta) is a protein-serine/threonine kinase of the AGC group and DMPK family. It is a key regulator of actin cytoskeleton and cell polarity. It is activated by binding the small G protein RhoA. D1113A substitution leads to abolished cleavage by caspase-3. Down-regulating ROCK1 may be useful strategy for inhibiting migration and invasion of glioma and gastric cancer.